"To solve the climate crisis, confidence in emissions data is crucial." Photo via Getty Images

Sustainability has been top of mind for all industries as we witness movements towards reducing carbon emissions. For instance, The Securities and Exchange Commission (SEC) proposed a new rule that requires companies to disclose certain climate-related activities in their reporting on a federal level. Now, industries and cities are scrambling to ensure they have strategies in the right place.

While the data behind sustainability poses challenges across industries, it is particularly evident in oil and gas, as their role in energy transition is of the utmost importance, especially in Texas. We saw this at the COP26 summit in Glasgow last November, for example, in the effort to reduce carbon emissions on both a national and international scale and keep global warming within 1.5 degrees Celsius.

The event also made it clear achieving this temperature change to meet carbon neutrality by 2030 won’t be possible if organizations rely on current methods and siloed data. In short, there is a data problem associated with recent climate goals. So, what does that mean for Houston’s oil and gas industry?

Climate is a critical conversation – and tech can help

Houston has long been considered the oil and gas capital of the world, and it is now the epicenter of energy transition. You can see this commitment by the industry in the nature of the conferences as well as the investment in innovation centers.

In terms of the companies themselves, over the past two years each of the major oil and gas players have organized and grown their low carbon business units. These units are focused on bringing new ideas to the energy ecosystem. The best part is they are not working alone but joining forces to find solutions. One of the highest profile examples is ExxonMobil’s Carbon Capture and Underground Storage project (CCUS) which directly supports the Paris Agreement.

Blockchain technology is needed to improve transparency and traceability in the energy sector and backing blockchain into day-to-day business is key to identifying patterns and making decisions from the data.

The recent Blockchain for Oil and Gas conference, for instance, focused on how blockchain can help curate emissions across the ecosystem. This year has also seen several additional symposiums and meetings – such as the Ion and Greentown Houston – that focus on helping companies understand their carbon footprint.

How do we prove the data?

The importance of harmonizing data will become even more important as the SEC looks to bring structure to sustainability reporting. As a decentralized, immutable ledger where data can be inputted and shared at every point of action, blockchain works by storing information in interconnected blocks and providing a value-add for insuring carbon offsets. To access the data inside a block, users first need to communicate with it. This creates a chain of information that cannot be hacked and can be transmitted between all relevant parties throughout the supply chain. Key players can enter, view, and analyze the same data points securely and with assurance of the data’s accuracy.

Data needs to move with products throughout the supply chain to create an overall number for carbon emissions. Blockchain’s decentralization offers value to organizations and their respective industries so that higher quantities of reliable data can be shared between all parties to shine a light on the areas they need to work on, such as manufacturing operations and the offsets of buildings. Baking blockchain into day-to-day business practice is key in identifying patterns over time and making data-backed decisions.

Oil and gas are key players

Cutting emissions is not a new practice of the oil and gas industry. In fact, they’ve been cutting emissions estimates by as much as 50 percent to avoid over-reporting.

The traditional process of reporting data has also been time-consuming and prone to human error. Manually gathering data across multiple sources of information delivers no real way to trace this information across supply chains and back to the source. And human errors, even if they are accidental, pose a risk to hefty fines from regulatory agencies.

It’s a now-or-never situation. The industry will need to pivot their approaches to data gathering, sharing, and reporting to commit to emissions reduction. This need will surely accelerate the use of technologies, like blockchain, to be a part of the energy transition. While the climate challenges we face are alarming, they provide the basis we need for technological innovation and the ability to accurately report emissions to stay in compliance.

The Energy Capital of the World, for good

To solve the climate crisis, confidence in emissions data is crucial. Blockchain provides that as well as transparency and reliability, all while maintaining the highest levels of security. The technology provides assurance that the data from other smart technologies, like connected sensors and the Internet of Things (IoT), is trustworthy and accurate.

The need for good data, new technology, and corporate commitment are all key to Houston keeping its title as the energy capital of the world – based on traditional fossil fuels as well as transitioning to clean energy.

------

John Chappell is the director of energy business development at BlockApps.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

3 Houston startups named most innovative in Texas by LexisNexis

report card

Three Houston companies claimed spots on LexisNexis's 10 Most Innovative Startups in Texas report, with two working in the geothermal energy space.

Sage Geosystems claimed the No. 3 spot on the list, and Fervo Energy followed closely behind at No. 5. Fintech unicorn HighRadius rounded out the list of Houston companies at No. 8.

LexisNexis Intellectual Property Solutions compiled the report. It was based on each company's Patent Asset Index, a proprietary metric from LexisNexis that identifies the strength and value of each company’s patent assets based on factors such as patent quality, geographic scope and size of the portfolio.

Houston tied with Austin, each with three companies represented on the list. Caris Life Sciences, a biotechnology company based in Dallas, claimed the top spot with a Patent Asset Index more than 5 times that of its next competitor, Apptronik, an Austin-based AI-powered humanoid robotics company.

“Texas has always been fertile ground for bold entrepreneurs, and these innovative startups carry that tradition forward with strong businesses based on outstanding patent assets,” Marco Richter, senior director of IP analytics and strategy for LexisNexis Intellectual Property Solutions, said in a release. “These companies have proven their innovation by creating the most valuable patent portfolios in a state that’s known for game-changing inventions and cutting-edge technologies.We are pleased to recognize Texas’ most innovative startups for turning their ideas into patented innovations and look forward to watching them scale, disrupt, and thrive on the foundation they’ve laid today.”

This year's list reflects a range in location and industry. Here's the full list of LexisNexis' 10 Most Innovative Startups in Texas, ranked by patent portfolios.

  1. Caris (Dallas)
  2. Apptronik (Austin)
  3. Sage Geosystems (Houston)
  4. HiddenLayer (Austin)
  5. Fervo Energy (Houston)
  6. Plus One Robotics (San Antonio)
  7. Diligent Robotics (Austin)
  8. HighRadius (Houston)
  9. LTK (Dallas)
  10. Eagle Eye Networks (Austin)

Sage Geosystems has partnered on major geothermal projects with the United States Department of Defense's Defense Innovation Unit, the U.S. Air Force and Meta Platforms. Sage's 3-megawatt commercial EarthStore geothermal energy storage facility in Christine, Texas, was expected to be completed by the end of last year.

Fervo Energy fully contracted its flagship 500 MW geothermal development, Cape Station, this spring. Cape Station is currently one of the world’s largest enhanced geothermal systems (EGS) developments, and the station will begin to deliver electricity to the grid in 2026. The company was recently named North American Company of the Year by research and consulting firm Cleantech Group and came in at No. 6 on Time magazine and Statista’s list of America’s Top GreenTech Companies of 2025. It's now considered a unicorn, meaning its valuation as a private company has surpassed $1 billion.

Meanwhile, HighRadius announced earlier this year that it plans to release a fully autonomous finance platform for the "office of the CFO" by 2027. The company reached unicorn status in 2020.

---

This article originally appeared on Energy Capital HTX.

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.